Literature DB >> 6209540

Relevance of experimental allergic encephalomyelitis to multiple sclerosis.

B G Arnason.   

Abstract

What the study of EAE has taught us that has relevance to human demyelinating diseases is discussed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6209540

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  15 in total

1.  Electrophysiological follow-up of acute and chronic experimental allergic encephalomyelitis in the Lewis rat.

Authors:  K Deguchi; H Takeuchi; H Miki; A Yamada; T Touge; S Terada; M Nishioka
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 2.  Statins as potential therapeutic agents in multiple sclerosis.

Authors:  Olaf Stüve; Thomas Prod'homme; Sawsan Youssef; Shannon Dunn; Oliver Neuhaus; Martin Weber; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 3.  B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis.

Authors:  P J Perrin; D Scott; C H June; M K Racke
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Authors:  Derrick P McCarthy; Maureen H Richards; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2012

Review 5.  Immune regulation of multiple sclerosis by CD8+ T cells.

Authors:  Sushmita Sinha; Farah R Itani; Nitin J Karandikar
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 6.  Pathogenesis of multiple sclerosis. A critical reappraisal.

Authors:  C M Poser
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 7.  Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis.

Authors:  K J Kennedy; W J Karpus
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

8.  The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).

Authors:  C Bolton
Journal:  Agents Actions       Date:  1992-01

Review 9.  Modulating co-stimulation.

Authors:  Vissia Viglietta; Samia J Khoury
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 10.  Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.

Authors:  Michael K Racke; Anne R Gocke; Mark Muir; Asim Diab; Paul D Drew; Amy E Lovett-Racke
Journal:  J Nutr       Date:  2006-03       Impact factor: 4.798
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.